Valuation: Zynex, Inc.

Market Cap 3.83M 3.32M 3.11M 2.83M 5.33M 365M 5.42M 36.42M 14.27M 183M 14.38M 14.06M 610M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 32.95M 30.85M 28.15M 52.96M 3.63B 53.85M 362M 142M 1.82B 143M 140M 6.06B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months+76.28%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
7/27/25 A Free

Chief Operating Officer

11,293 0.0355%
6/5/25 A Tax

Chief Financial Officer

8,982 0.0282%
5/15/25 A Free

Director

10,000 0.0314%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-96.13%-99.29% 1.69M
+0.89%+7.13%+30.84%+11.26% 224B
-0.92%+6.50%+3.84%-18.78% 146B
+2.00%+8.95%-14.97%+31.77% 142B
+1.45%+4.28%-50.18%+0.31% 74.19B
+1.77%+4.53%+19.83%+17.94% 53.99B
+1.07%+1.51%-13.73%-16.11% 50.85B
+0.52%+7.39%+30.98%+17.84% 42.22B
+0.78%+4.78%+48.59%+42.29% 40.75B
-0.26%+3.54%-0.34%+1.62% 32.86B
Average +1.19%+198.25%-4.13%-1.11% 80.61B
Weighted average by Cap. +0.73%+312.79%+6.53%+8.66%

Financials

2023 2024
Net sales 184M 160M 150M 136M 257M 17.58B 261M 1.75B 687M 8.8B 692M 677M 29.36B 192M 167M 156M 142M 268M 18.35B 272M 1.83B 717M 9.18B 722M 706M 30.64B
Net income 9.73M 8.43M 7.9M 7.2M 13.56M 928M 13.78M 92.58M 36.27M 465M 36.54M 35.74M 1.55B 2.99M 2.59M 2.43M 2.22M 4.17M 286M 4.24M 28.48M 11.16M 143M 11.24M 11M 477M
Net Debt 31.59M 27.38M 25.63M 23.38M 44M 3.01B 44.74M 300M 118M 1.51B 119M 116M 5.03B 34.19M 29.63M 27.74M 25.31M 47.63M 3.26B 48.43M 325M 127M 1.63B 128M 126M 5.45B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock